BioCentury
ARTICLE | Clinical News

DS003: Phase I started

November 23, 2015 8:00 AM UTC

IPM began the double-blind, placebo-controlled, Belgian Phase I IPM 042 trial to evaluate single 1, 3 and 10 mg DS003 vaginal tablets in about 36 healthy female volunteers. The non-profit IPM has a ro...